search
Back to results

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

Primary Purpose

Attention Deficit Disorder, ADHD

Status
Completed
Phase
Not Applicable
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
repetitive Transcranial Magnetic Stimulation
Sponsored by
University of Tehran
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Attention Deficit Disorder focused on measuring rTMS, ADHD, ADD, fMRI

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Normal intelligence level (>90) Diagnosis of ADD by a psychiatrist using the ADHD-RS-IV with Adult Prompts Exclusion Criteria: Scores of 21 or more on BDI and/or BAI History of head trauma History of a major psychological or neurological condition Presence of metal in the head History of seizures Serious cardiovascular disease Use of medications with an impact on cognitive functions during the treatment window (patients with a constant and stable dose were included) Recent use of alcohol or substance abuse

Sites / Locations

  • National Brain Mapping Lab

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Active rTMS

Arm Description

Participants in this one and only arm in the current study received active repetitive transcranial magnetic stimulation.

Outcomes

Primary Outcome Measures

Change in performance
Shortened version (4 min) of the continuous go/no-go task: gradual-onset continuous performance task (gradCPT)

Secondary Outcome Measures

Change in self-report attention scores
The 6-item ASRS-V1.1 Adult ADHD Self-Report
Change in investigator-rated attention scores
Investigator-Rated Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-IV (I-ADHD RS-IV) with adult prompts

Full Information

First Posted
September 1, 2023
Last Updated
September 12, 2023
Sponsor
University of Tehran
search

1. Study Identification

Unique Protocol Identification Number
NCT06030024
Brief Title
Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder
Official Title
An Open-lable Investigation of the Effect of rTMS on Attention in an Adult Sample Suffering From ADD
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
February 1, 2023 (Actual)
Study Completion Date
March 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Tehran

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the current open-lable study was to use low-frequency repetitive transcranial magnetic stimulation (rTMS) to improve the attention deficits in a sample of adult patients suffering from attention deficit disorder. Participants received 10 sessions of rTMS over Fz (located using the EEG 10-20 international system) and underwent assessments of their attentional capacity using the gradCPT task in an fMRI scanner, before and after the intervention. Other behavioral assessments of their attention symptoms have also been conducted.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Attention Deficit Disorder, ADHD
Keywords
rTMS, ADHD, ADD, fMRI

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active rTMS
Arm Type
Experimental
Arm Description
Participants in this one and only arm in the current study received active repetitive transcranial magnetic stimulation.
Intervention Type
Device
Intervention Name(s)
repetitive Transcranial Magnetic Stimulation
Intervention Description
Magnetic pulses delivered to the Fz area of the brain in a low frequency (1 Hz) manner.
Primary Outcome Measure Information:
Title
Change in performance
Description
Shortened version (4 min) of the continuous go/no-go task: gradual-onset continuous performance task (gradCPT)
Time Frame
Up to 10 days, i.e., before and after the completion of the 10 sessions of rTMS
Secondary Outcome Measure Information:
Title
Change in self-report attention scores
Description
The 6-item ASRS-V1.1 Adult ADHD Self-Report
Time Frame
Baseline, after 5 days of stimulation, after 10 days of stimulation; Range= 0-6; Higher scores represent worse outcome
Title
Change in investigator-rated attention scores
Description
Investigator-Rated Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale-IV (I-ADHD RS-IV) with adult prompts
Time Frame
Baseline, after 5 days of stimulation, after 10 days of stimulation; Range:0 - 54; Higher scores represent worse outcome

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Normal intelligence level (>90) Diagnosis of ADD by a psychiatrist using the ADHD-RS-IV with Adult Prompts Exclusion Criteria: Scores of 21 or more on BDI and/or BAI History of head trauma History of a major psychological or neurological condition Presence of metal in the head History of seizures Serious cardiovascular disease Use of medications with an impact on cognitive functions during the treatment window (patients with a constant and stable dose were included) Recent use of alcohol or substance abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reza Rostami, M.D
Organizational Affiliation
University of Tehran
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Fatemeh Soltani, MSc
Organizational Affiliation
University of Tehran
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Brain Mapping Lab
City
Tehran
ZIP/Postal Code
1439957131
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

We'll reach out to this number within 24 hrs